Literature DB >> 32975605

Higher Incidence of Protein-Losing Enteropathy in Patients with Single Systemic Right Ventricle.

Alyssa M Bernardi1, Sylvestor Moses2, Brent J Barber3, Marlys H Witte4, Michael D Seckeler5.   

Abstract

Patients with single ventricle congenital heart disease are at risk of unpredictable protein-losing enteropathy (PLE) after surgical palliation. Based on prior reports of physiologic differences for patients with single morphologic right versus left ventricles, we hypothesized that those with right ventricular morphology would have a higher incidence of PLE. We performed a retrospective review of > 15 million pediatric hospitalizations from the Healthcare Cost and Utilization Project KID 2000-2012 databases for admissions 5-21 years old with ICD-9 codes for hypoplastic left heart syndrome (HLHS) and tricuspid atresia (TA) with and without PLE. Incidence of PLE was compared between those with HLHS and TA. In addition, outcomes and costs were compared between admissions with and without PLE and between HLHS and TA. Of 1623 HLHS admissions, 289 (17.8%) had PLE, and of 926 TA admissions, 58 (5.9%) had PLE (p < 0.001). Admissions with PLE were older compared to those without PLE (12 vs 10 years, p < 0.001) and PLE onset occurred at a younger age for HLHS than TA (11 vs 14 years, p < 0.001). There were no differences in hospital outcomes or costs. Review of this large administrative database suggests a higher incidence of PLE in patients with HLHS and a younger age of onset compared to those with TA. These data suggest that a single systemic right ventricle may be an independent risk factor for developing PLE.

Entities:  

Keywords:  Congenital heart defects; Fontan; Protein-losing enteropathy; Single ventricle

Mesh:

Year:  2020        PMID: 32975605      PMCID: PMC7867645          DOI: 10.1007/s00246-020-02468-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

Review 1.  Protein-losing enteropathy after Fontan operation.

Authors:  Jack Rychik
Journal:  Congenit Heart Dis       Date:  2007 Sep-Oct       Impact factor: 2.007

2.  Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group.

Authors:  L Mertens; D J Hagler; U Sauer; J Somerville; M Gewillig
Journal:  J Thorac Cardiovasc Surg       Date:  1998-05       Impact factor: 5.209

3.  Proposal for Prevention or Alleviation of Protein/Lymph-Losing Enteropathy (PLE/LLE) After Fontan Circulation Treatment of Univentricular Hearts: Restoration of Lymph Balance With a "Lymphatic Right-to-Left Shunt."

Authors:  H James; M H Witte; M Bernas; B Barber
Journal:  Lymphology       Date:  2016-09       Impact factor: 1.286

4.  Modifications of the Fontan operation applicable to patients with left atrioventricular valve atresia or single atrioventricular valve.

Authors:  F J Puga; M Chiavarelli; D J Hagler
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

5.  Surgical repair of tricuspid atresia.

Authors:  F Fontan; E Baudet
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

6.  Validity of hospital discharge data for identifying infants with cardiac defects.

Authors:  Barbara Kathleen Frohnert; Richard Charles Lussky; Maureen Anne Alms; Nancy J Mendelsohn; Daniel Michael Symonik; Myron Clifford Falken
Journal:  J Perinatol       Date:  2005-11       Impact factor: 2.521

7.  Influence of ventricular morphology on outcome after the Fontan procedure.

Authors:  P R Julsrud; T J Weigel; J A Van Son; W D Edwards; D D Mair; D J Driscoll; G K Danielson; F J Puga; K P Offord
Journal:  Am J Cardiol       Date:  2000-08-01       Impact factor: 2.778

8.  Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association.

Authors:  Jack Rychik; Andrew M Atz; David S Celermajer; Barbara J Deal; Michael A Gatzoulis; Marc H Gewillig; Tain-Yen Hsia; Daphne T Hsu; Adrienne H Kovacs; Brian W McCrindle; Jane W Newburger; Nancy A Pike; Mark Rodefeld; David N Rosenthal; Kurt R Schumacher; Bradley S Marino; Karen Stout; Gruschen Veldtman; Adel K Younoszai; Yves d'Udekem
Journal:  Circulation       Date:  2019-07-01       Impact factor: 29.690

9.  Ventricular morphology is a determinant of diastolic performance in patients with single ventricle physiology undergoing stage 3 palliative surgery.

Authors:  Michael D Seckeler; Edward O'Leary; K Anitha Jayakumar
Journal:  Pediatr Cardiol       Date:  2014-12-09       Impact factor: 1.655

10.  Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery.

Authors:  Paul Khairy; Susan M Fernandes; John E Mayer; John K Triedman; Edward P Walsh; James E Lock; Michael J Landzberg
Journal:  Circulation       Date:  2007-12-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.